FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | |||
|
||||
Member
|
This article came out yesterday. Very interesting -- I've never heard of this drug--efalizumab for psoriasis. About 46,000 people are on it worldwide. 3 PML cases (2 recent) causing concern. After 3 years on the drug the risk of getting PML is 1:1100. Some doctors are now calling for people to get off it because they don't view that as a risk worth taking.
http://www.medpagetoday.com/MeetingCoverage/SDEF/12849
__________________
On Tysabri and love it. . |
|||
![]() |
![]() |
"Thanks for this!" says: | SallyC (02-12-2009) |
|
|
![]() |
||||
Thread | Forum | |||
good explainations for drug depletions & drug interactions | Parkinson's Disease | |||
Drug Company Funding Of Drug Trials Greatly Influences Outcome | Parkinson's Disease Clinical Trials | |||
Drug Company Funding Of Drug Trials Greatly Influences Outcome | Parkinson's Disease | |||
"...pricing drugs...not on how much drug costs to develop, but...benefit drug brings | Parkinson's Disease |